why choose us

Clinical Trials Search

Showing 5,030 of 132,085 result(s)
Effect of Vericiguat on Acute Coronary Syndrome( ACS?Patients With Ejection Fraction <45%

Status: COMPLETED

Condition: Acute Coronary Syndrome

Interventions:

Date: 2024-03-06

Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults

Status: COMPLETED

Condition: Zika

Interventions: 0.45mL (milliliter), Day 1 and 29

Date: 2024-03-06

Intraoperative Electroencephalographic Biomarkers of Postoperative Pain

Status: COMPLETED

Condition: Pain Postoperative

Interventions:

Date: 2024-03-06

Real-World Outcomes in COPD Patients Starting Trixeo (Budesonide;Glycopyrronium;Formoterol) in Spain.

Status: COMPLETED

Condition: Chronic Obstructive Pulmonary Disease (COPD)

Interventions:

Date: 2024-03-06

Effects of Intact and Disrupted Milk Fat Globule Membrane on Postprandial Metabolic Response to High-fat Dairy in Healthy Individuals

Status: COMPLETED

Condition: Postprandial Lipid Metabolism

Interventions: 1) Sandwich with butter-like dairy product (40g milk fat) with intact MFGM.

Date: 2024-03-06

The FEMA Study: Feasibility of Exercise in Patients With Metastatic Breast Cancer and Adiposity

Status: COMPLETED

Condition: Metastatic Breast Cancer

Interventions: 12-week physical activity program with training 3 times a week.
The training consists of high-intensity training such as weight-lifting and cardi

Date: 2024-03-06

Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis

Status: COMPLETED

Condition: Actinic Keratosis

Interventions: Participants will be instructed to self-apply topical bimiralisib gel on the treatment area once daily for 2 weeks

Date: 2024-03-06

Tuvusertib (M1774) Human Mass Balance and Absolute Bioavailability Study (DDRIVER Solid Tumors 303)

Status: COMPLETED

Condition: Solid Tumor

Interventions: Participants will receive single oral dose of Tuvusertib containing a [14C] Tuvusertib microtracer solution on Day 1 of period 1 under fasted conditio

Date: 2024-03-06

Real-World Observational Study on Patient-Reported Outcomes in the Treatment of Insomnia With Daridorexant in Canada

Status: COMPLETED

Condition: Insomnia

Interventions: DRUG: Daridorexant 50 mg - As indicated by the physician

Date: 2024-03-06

Hypoglycemia Biomarkers to Predict Timing of a Hypoglycemic Event

Status: COMPLETED

Condition: Hypoglycemia

Interventions:

Date: 2024-03-06